The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 825 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The firm also provides management services to over 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenue
461
393
324
252
203
187
Revenue Growth (YoY)
22%
21%
28.99%
24%
9%
21%
Cost of Revenue
392
339
264
200
162
150
Gross Profit
68
53
59
52
40
36
Selling, General & Admin
102
107
113
119
83
41
Research & Development
--
--
--
--
--
--
Operating Expenses
109
114
119
124
86
45
Other Non Operating Income (Expenses)
-14
2
0
85
29
-6
Pretax Income
-66
-64
-83
0
-11
-14
Income Tax Expense
0
0
0
0
0
0
Net Income
-54
-53
-67
0
-10
-14
Net Income Growth
-5%
-21%
--
-100%
-28.99%
250%
Shares Outstanding (Diluted)
97.47
75.04
73.74
80.6
73.2
74.6
Shares Change (YoY)
28.99%
2%
-9%
10%
-2%
0%
EPS (Diluted)
-0.56
-0.7
-0.92
0
-0.15
-0.19
EPS Growth
-27%
-23%
--
-100%
-21%
280%
Free Cash Flow
-27
-30
-40
-67
-35
0
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
14.75%
13.48%
18.2%
20.63%
19.7%
19.25%
Operating Margin
-8.89%
-15.26%
-18.51%
-28.57%
-22.16%
-4.27%
Profit Margin
-11.71%
-13.48%
-20.67%
0%
-4.92%
-7.48%
Free Cash Flow Margin
-5.85%
-7.63%
-12.34%
-26.58%
-17.24%
0%
EBITDA
-34
-54
-55
-68
-42
-5
EBITDA Margin
-7.37%
-13.74%
-16.97%
-26.98%
-20.68%
-2.67%
D&A For EBITDA
7
6
5
4
3
3
EBIT
-41
-60
-60
-72
-45
-8
EBIT Margin
-8.89%
-15.26%
-18.51%
-28.57%
-22.16%
-4.27%
Effective Tax Rate
0%
0%
0%
0%
0%
0%
Follow-Up Questions
What are Oncology Institute Inc's key financial statements?
According to the latest financial statement (Form-10K), Oncology Institute Inc has a total asset of $172, Net loss of $-53
What are the key financial ratios for TOI?
Oncology Institute Inc's Current ratio is 1.01, has a Net margin is -13.48, sales per share of $5.23.
How is Oncology Institute Inc's revenue broken down by segment or geography?
Oncology Institute Inc largest revenue segment is Patient Services, at a revenue of 213,504,000 in the most earnings release.For geography, United States is the primary market for Oncology Institute Inc, at a revenue of 324,239,000.
Is Oncology Institute Inc profitable?
no, according to the latest financial statements, Oncology Institute Inc has a net loss of $-53
Does Oncology Institute Inc have any liabilities?
yes, Oncology Institute Inc has liability of 169
How many outstanding shares for Oncology Institute Inc?
Oncology Institute Inc has a total outstanding shares of 75.73